Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage

Diabetic Vitreous Hemorrhage Clinical Trial

Official title:
Intravitreal Aflibercept Injection With Panretinal Photocoagulation Versus Early Vitrectomy for Diabetic Vitreous Hemorrhage

Status Completed

Clinical Trial Summary

Prospective study comparing efficacy and safety of intravitreal aflibercept injection and panretinal photocoagulation to early vitrectomy for patients with diabetic vitreous hemorrhage.

Clinical Trial Description

Selected patients were divided into two groups, Group I for whom intravitreal aflibercept injection followed by panretinal photocoagulation was done and group II for whom early vitrectomy was done. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04153253
Study type	Interventional
Source	Al Hadi Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	March 7, 2018
Completion date	September 29, 2019

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05318742` - Panretinal Photocoagulation During Vitrectomy for Diabetic Vitreous Hemorrhage	N/A
	Completed	`NCT05739539` - Assessment of Retinal Vascular Changes With and Without ILM Peeling in Diabetic Vitrectomy Using OCT-A.	N/A